Rauber, C., Roberti, M. P., Vehreschild, M. J., Tsakmaklis, A., Springfeld, C., Teufel, A., . . . Dill, M. T. (2025). Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab$da multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial). BMJ open, 15(9), . https://doi.org/10.1136/bmjopen-2024-097802
Chicago-Zitierstil (17. Ausg.)Rauber, Conrad, et al. "Protocol: Faecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/bevacizumab$da Multicentre, Randomised, Placebo-controlled, Double-blind Phase II Trial (the FLORA Trial)." BMJ Open 15, no. 9 (2025). https://doi.org/10.1136/bmjopen-2024-097802.
MLA-Zitierstil (9. Ausg.)Rauber, Conrad, et al. "Protocol: Faecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/bevacizumab$da Multicentre, Randomised, Placebo-controlled, Double-blind Phase II Trial (the FLORA Trial)." BMJ Open, vol. 15, no. 9, 2025, https://doi.org/10.1136/bmjopen-2024-097802.